🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Greg Hart

2 posts
Read More

Coursera (NYSE: COUR) plunges 26% as Udemy savings accelerate. Where is the growth?

Coursera shares collapsed after management warned that underlying revenue could remain weak into 2027, despite accelerating its US$115 million annual synergy programme following the Udemy merger. With consumer revenue declining and its AI-native Project Helix still awaiting wider commercial rollout, investors face a difficult question about whether cost savings can restore sustainable growth.